Foldax Inc (Foldax) is a medical device company that manufactures bio polymeric heart valves. The company product portfolio includes lifepolymer, an advanced biopolymer material developed for long-lasting heart valves. Foldax serves in the therapeutic areas of aortic, mitral and tricuspid valve diseases. The company was funded by Kairos Ventures. Its products find its application in various fields including industrial and medical devices. The company collaborates with clinicians and researchers for designing and manufacturing heart valves. Foldax is headquartered in Salt Lake City, Utah, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Foldax Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- Foldax Inc Company Overview
- Foldax Inc Company Snapshot
- Foldax Inc Pipeline Products and Ongoing Clinical Trials Overview
- Foldax Inc - Pipeline Analysis Overview
- Foldax Inc - Key Facts
- Foldax Inc - Major Products and Services
- Foldax Inc Pipeline Products by Development Stage
- Foldax Inc Ongoing Clinical Trials by Trial Status
- Foldax Inc Pipeline Products Overview
- Tria Biopolymer Mitral Surgical Heart Valve
- Tria Biopolymer Mitral Surgical Heart Valve Product Overview
- Tria Biopolymer Mitral Surgical Heart Valve Clinical Trial
- TRIA Biopolymer Surgical Aortic Heart Valve
- TRIA Biopolymer Surgical Aortic Heart Valve Product Overview
- TRIA Biopolymer Surgical Aortic Heart Valve Clinical Trial
- Tria Surgical Tricuspid Heart Valve
- Tria Surgical Tricuspid Heart Valve Product Overview
- Tria Transcatheter Aortic Valve Replacement Device
- Tria Transcatheter Aortic Valve Replacement Device Product Overview
- Tria Transcatheter Mitral Valve Replacement Device
- Tria Transcatheter Mitral Valve Replacement Device Product Overview
- Tria Transcatheter Tricuspid Valve Replacement Device
- Tria Transcatheter Tricuspid Valve Replacement Device Product Overview
- Foldax Inc - Key Competitors
- Foldax Inc - Key Employees
- Foldax Inc - Locations And Subsidiaries
- Head Office
- Recent Developments
- Foldax Inc, Recent Developments
- Jun 12, 2024: Foldax reveals positive results from TRIA heart valve trial
- Feb 27, 2024: Foldax Signs Manufacturing Agreement with Dolphin Life Science India LLP to Expedite Upcoming Commercial Availability
- Nov 27, 2023: Foldax Completes Enrollment in India Clinical Trial Evaluating TRIA Polymer Surgical Mitral Heart Valve
- Aug 01, 2023: First Patients Outside of U.S. Treated with TRIA Polymer Surgical Mitral Heart Valve
- May 03, 2022: First patients outside of U.S. treated with TRIA biopolymer surgical aortic heart valve in India clinical trial
- Dec 21, 2021: First clinical study on TRIA Biopolymer Heart Valve shows excellent one-year performance
- Dec 07, 2021: Foldax receives approval for clinical trial of TRIA Biopolymer Surgical Aortic Heart Valve in India
- Sep 28, 2021: Foldax completes enrollment in early feasibility study for TRIA biopolymer surgical aortic heart valve
- May 25, 2021: Foldax announces successful first human use of Tria Biopolymer Mitral Heart Valve
- Jan 26, 2021: Foldax Biopolymer shown to possess ideal properties for heart valve in new published paper
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- Foldax Inc Pipeline Products and Ongoing Clinical Trials Overview
- Foldax Inc Pipeline Products by Equipment Type
- Foldax Inc Pipeline Products by Indication
- Foldax Inc Ongoing Clinical Trials by Trial Status
- Foldax Inc, Key Facts
- Foldax Inc, Major Products and Services
- Foldax Inc Number of Pipeline Products by Development Stage
- Foldax Inc Pipeline Products Summary by Development Stage
- Foldax Inc Ongoing Clinical Trials by Trial Status
- Foldax Inc Ongoing Clinical Trials Summary
- Tria Biopolymer Mitral Surgical Heart Valve - Product Status
- Tria Biopolymer Mitral Surgical Heart Valve - Product Description
- Tria Biopolymer Mitral Surgical Heart Valve - Clinical Investigation for the Foldax Tria Mitral Valve - India
- Tria Biopolymer Mitral Surgical Heart Valve - Early Feasibility Study for the Foldax TRIA Mitral Heart Valve Replacement Investigational Device Exemption
- TRIA Biopolymer Surgical Aortic Heart Valve - Product Status
- TRIA Biopolymer Surgical Aortic Heart Valve - Product Description
- TRIA Biopolymer Surgical Aortic Heart Valve - Clinical Investigation for the Foldax Tria Aortic Heart Valve India
- TRIA Biopolymer Surgical Aortic Heart Valve - Early Feasibility Study for the Foldax Tria Aortic Heart Valve
- Tria Surgical Tricuspid Heart Valve - Product Status
- Tria Surgical Tricuspid Heart Valve - Product Description
- Tria Transcatheter Aortic Valve Replacement Device - Product Status
- Tria Transcatheter Aortic Valve Replacement Device - Product Description
- Tria Transcatheter Mitral Valve Replacement Device - Product Status
- Tria Transcatheter Mitral Valve Replacement Device - Product Description
- Tria Transcatheter Tricuspid Valve Replacement Device - Product Status
- Tria Transcatheter Tricuspid Valve Replacement Device - Product Description
- Foldax Inc, Key Employees
- Glossary
- Foldax Inc Pipeline Products by Equipment Type
- Foldax Inc Pipeline Products by Development Stage
- Foldax Inc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Ethicon US LLC
- Edwards Lifesciences Corp
- Artivion Inc
